Guru Ownership Trend
Guru Analysis for Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $105.09 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $35.55 M net inflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 560.9%. Conversely, Cliff Asness reduced exposure by 2.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Mirum Pharmaceuticals, Inc. (MIRM)
Major holders include Renaissance Technologies (RenTech) ($53.77 M), Steven Cohen ($32.06 M), Ken Fisher ($8.6 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.07 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $35.55 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited MIRM. The total reported sell value was $475,254.73.
Yes, 2 managers opened new positions in MIRM, and 3 increased their existing holdings. The total reported buy value was $36.03 M.